Generic Name: Ipratropium bromide
Product Name: Atrovent MDI
- Used for severe acute asthma
- Used for maintenance treatment in COPD and severe asthma
- Used as alternative to or in combination with beta 2 agonists in COPD
Promote widening of airway diameter.
- MDI: 40 mcg, repeat 3-4 times daily as necessary; up to 80mcg 3-4 times daily may be needed.
- Neb: 250-500mcg up to 3-4 times daily (dilute solution for nebulisation with 0.9% sodium chloride solution)
- MDI (child<6years): 20mcg, 3 times daily.
- MDI (child 6-12 years): 20-40 mcg, 3-4 times daily as necessary.
- Neb: 250mcg up to 3 times daily (dilute solution for nebulisation with 0.9% sodium chloride solution)
Common side effects
- Dry mouth.
- Throat irritation.
Uncommon side effects
- Urinary retention (there is a risk of aggravation of symptoms in patients with prostatic hypertrophy)
- Acute angle closure glaucoma (there is a risk of aggravation of symptoms in patients with coexisting glaucoma)
- Allergic reactions
- Ipratropium MDI should not be used by patients with allergy to soya lecithin or related food products such as soya bean and peanuts.
For further information talk to your doctor.